# EDGAR Filing Document

**Accession Number:** 0000849146
**File Stem:** 0001628280-25-051641
**Filing Date:** 2025-11
**Character Count:** 8702
**Document Hash:** 1be87f274ab1498633a35c4ccb12b74c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-051641.hdr.sgml**: 20251112

**ACCESSION NUMBER**: 0001628280-25-051641

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20251106

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20251112

**DATE AS OF CHANGE**: 20251112

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lifevantage Corp
- **CENTRAL INDEX KEY:** 0000849146
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 900224471
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35647
- **FILM NUMBER:** 251473561

**BUSINESS ADDRESS:**
- **STREET 1:** 3300 TRIUMPH BLVD
- **STREET 2:** SUITE 700
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
- **BUSINESS PHONE:** 801-432-9000

**MAIL ADDRESS:**
- **STREET 1:** 3300 TRIUMPH BLVD
- **STREET 2:** SUITE 700
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LIFELINE THERAPEUTICS, INC.
- **DATE OF NAME CHANGE:** 20041019

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** YAAK RIVER RESOURCES INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ANDRAPLEX CORP
- **DATE OF NAME CHANGE:** 19920406

?xml version='1.0' encoding='ASCII'? lfvn-20251106

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

______________________________

**FORM 8-K** 

______________________________

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): November 6, 2025**

______________________________

**LIFEVANTAGE CORPORATION**

**(Exact name of registrant as specified in its charter)**

______________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-35647** | **90-0224471** |
| (State or other jurisdiction of<br>incorporation or organization) | (Commission File Number) | (IRS Employer<br>Identification No.) |

---

**3300 Triumph Blvd., Suite 700, Lehi, Utah 84043** 

(Address of principal executive offices, including zip code)

**Registrant's telephone number, including area code: (801) 432-9000** 

_____________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Common Stock, par value $0.0001** | **LFVN** | **The Nasdaq Stock Market LLC** |
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |

---

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.07&nbsp;&nbsp;&nbsp;&nbsp;Submission of Matters to a Vote of Security Holders.**

LifeVantage Corporation (the "Company") held its fiscal year 2026 annual meeting of stockholders on November 6, 2025 (the "Annual Meeting"). Of the 12,691,009 shares of the Company's common stock outstanding as of the record date, 9,571,454 shares, or 75.41% were represented at the Annual Meeting either in person or by proxy. The following proposals were submitted to a vote of the Company's stockholders at the Annual Meeting:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. To elect the following seven director nominees to the Company's board of directors to hold office until the Company's fiscal year 2027 annual meeting of stockholders or until their respective successors are elected and qualified:

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Rajendran Anbalagan | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Dayton Judd |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Michael A. Beindorff | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ms. Cynthia Latham |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Steven R. Fife | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Darwin K. Lewis |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Raymond B. Greer |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. To approve, on an advisory basis, a resolution approving the compensation of the Company's named executive officers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. To ratify the selection of Deloitte & Touche, LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending June 30, 2026; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. To approve an amendment to the 2017 Long-Term Incentive Plan.

The proposals submitted to a vote of the Company's stockholders at the Annual Meeting are more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission (the "SEC") on September 19, 2025.

The final voting results of each proposal were as follows:

<u>Proposal 1 – Election of Directors</u>.

The Company's stockholders elected each of the seven director nominees listed above to the Company's board of directors (the "Board") to serve until the Company's fiscal year 2027 annual meeting of stockholders or until their respective successors are elected and qualified. Votes cast were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| Mr. Rajendran Anbalagan | 7559064 | 102322 | 36420 | 1873648 |
| Mr. Michael A. Beindorff | 5494579 | 2169807 | 33420 | 1873648 |
| Mr. Steven R. Fife | 7634222 | 31187 | 32397 | 1873648 |
| Mr. Raymond B. Greer | 5715100 | 1949855 | 32851 | 1873648 |
| Mr. Dayton Judd | 6961169 | 703786 | 32851 | 1873648 |
| Ms. Cynthia Latham | 7463640 | 191438 | 42728 | 1873648 |
| Mr. Darwin K. Lewis | 5640894 | 1999965 | 56947 | 1873648 |

---

<u>Proposal 2 – Approval, on an Advisory Basis, of a Resolution Approving the Compensation of the Company's Named Executive Officers</u>.

The Company's stockholders approved, on an advisory and non-binding basis, the compensation of the Company's named executive officers. Votes cast were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 7,420,820 | 246,406 | 30,580 | 1,873,648 |

---

<u>Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm.</u>

------

The Company's stockholders ratified the selection of Deloitte & Touche, LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026. Votes cast were as follows:

---

| | | |
|:---|:---|:---|
| **For** | **Against** | **Abstain** |
| 9,539,267 | 30,720 | 1,467 |

---

<u>Proposal 4 – Approval of an Amendment to the Company's 2017 Long-Term Incentive Plan.</u> 

The Company's stockholders approved the amendment to the Company's 2017 Long-Term Incentive Plan. Votes cast were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 5,382,441 | 2,308,926 | 6,439 | 1,873,648 |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| Date: November 12, 2025 | LIFEVANTAGE CORPORATION<br>By: <u>/s/ Steven R. Fife</u><br>Name: Steven R. Fife<br>Title: President and Chief Executive Officer |

---